Article Details
Retrieved on: 2022-01-25 18:12:50
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The FDA cited monoclonal antibodies as being less effective against the Omicron variant in their decision to rescind their earlier approval of the ...
Article found on: www.contagionlive.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here